Percutaneous Mitral Valve Delivery System

Tech ID: 23474 / UC Case 2013-844-0

Brief Description

Valvular heart disease is the third most common cause of cardiovascular disease in the United States. Although replacement of dysfunctional valves markedly reduces the morbidity and the mortality associated with severe valvular disease, a substantial number of patients with valvular heart disease go untreated or undertreated either due to the lack of access to affordable healthcare, or due to comorbidities that preclude successful surgical valve replacement.

The percutaneous approach to valve replacement is a welcome option for many patients since it bypasses aggressive surgery and reduces the associated comorbidities based on the minimally invasive nature of the procedure. Percutaneous valve replacement avoids open heart surgery in severely ill patients and reduces the number of reoperations in young patients with congenital heart defects. Percutaneous heart valve replacement has been developed and is being evaluated for aortic valve stenosis.

Each year there are more than half a million patients discharged with the diagnosis of mitral regurgitation. About 18,000 patients undergo mitral valve surgery. However there are no on-going clinical trials evaluating a percutaneous valve delivery system for mitral valve replacement due to the mitral valve’s unique anatomical position.

Researchers at the University of California, Irvine have developed a method and device for the percutaneous delivery of a mitral valve.

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 9,968,445 05/15/2018 2013-844
United States Of America Published Application 20170252163 09/07/2017 2013-844
 

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Other Information

Keywords

Heart, Valve, Mitral, Percutaneous

Categorized As


5270 California Avenue / Irvine,CA
92697-7700 / Tel: 949.824.2683
  • Facebook
  • Twitter
  • Twitter
  • Twitter
  • Twitter